spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:   Cephalon 

 HSMN NewsFeed - 18 Jan 2023
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Jul 2022
HotSpot Therapeutics Appoints Paul Thibodeau, Ph.D., as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2022
Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2022
ARS Pharmaceuticals Expands Executive Leadership Team with Addition of Pharmaceutical Commercialization Veterans
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2019
Zyla Life Sciences Appoints Dr. H. Jeffrey Wilkins as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Apr 2019
Neurelis Announces Completion of Senior Management Team Buildout to Support the Anticipated Commercial Launch of VALTOCO(TM)
Biopharmaceuticals Drug Delivery Neurology Personnel
 HSMN NewsFeed - 18 Mar 2019
Bryan Reasons Joins Mallinckrodt as the Company's Chief Financial Officer (CFO)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2019
Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Sep 2018
Biohaven Appoints Bob Repella to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Aug 2018
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jan 2018
Disarm Therapeutics Appoints Thomas Engber as Senior Vice President, Head of Neuropharmacology and Translational Sciences
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 6 Sep 2017
Oxeia Biopharmaceuticals, Inc. Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 6 Jun 2017
Axovant Strengthens Executive Team with Key Management Appointments
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 6 Mar 2017
Recro Pharma Appoints Bryan Reasons to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2017
CTI BioPharma Announces Appointment of Hematology/Oncology Clinical Expert Adam Craig, M.D., Ph.D., as President and CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Nov 2016
Atrin Pharmaceuticals Elects Jeffrey M. Dayno, MD to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Sep 2016
Assembly Biosciences Announces Key Additions to Microbiome Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2015
EUSA Pharma Successfully Launches as an Independent Profitable Pharmaceutical Business with Global Reach and a Portfolio of Specialty Products Acquired from Jazz Pharmaceuticals
Biopharmaceuticals Acquisitions Product Launch
 HSMN NewsFeed - 9 Jan 2014
Sorrento Therapeutics Welcomes William S. Marth as Chairman of the Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Jan 2014
NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indications; Raises $21.5 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 29 Oct 2013
AMAG Pharmaceuticals Appoints Robert F. Kaper, M.D. as Senior Vice President of Medical and Scientific Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Sep 2013
Alkermes Expands Senior Management Team
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 19 Aug 2013
TetraLogic Pharmaceuticals Announces New Executives
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Jan 2013
Inotek Pharmaceuticals Appoints David R. King as Executive Chairman
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 26 Nov 2012
ImmunoGen, Inc. Appoints Dr. Charles Morris as Chief Development Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 26 Oct 2012
Teva Receives Approval For SYNRIBO(TM) (Omacetaxine Mepesuccinate) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Sep 2012
Teva Pharmaceutical Announces the Appointment of Professor Itzhak Krinsky as Chairman of Teva Japan and Teva South Korea and Head of Business Development in Asia-Pacific
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2012
Teva Announces FDA Grants Approval for Tbo-filgrastim for the Treatment of Chemotherapy-Induced Neutropenia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Aug 2012
Teva Receives FDA Acceptance of Its New Drug Application for Quartette(TM) (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for the Prevention of Pregnancy
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Aug 2012
Teva Pharmaceutical Announces New Appointments of President and Chief Executive Officer, Global Operations and Executive Vice President, Community and Institutional Affairs
Biopharmaceuticals Generics Personnel
 HSMN NewsFeed - 9 Jul 2012
Onyx Pharmaceuticals Names John E. Osborn Senior Vice President, Global Corporate Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jun 2012
Teva Announces Favorable Court Ruling in COPAXONE(R) Patent Infringement Litigation
Biopharmaceuticals Generics Neurology Litigation
 HSMN NewsFeed - 30 May 2012
Polynoma Appoints John Chiplin, Ph.D., Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Apr 2012
Par Pharmaceutical Begins Shipment of Generic Provigil(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 5 Apr 2012
FDA Decides Teva is Sole First-to-File on Provigil(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 Jan 2012
Yaupon Changes Name to Ceptaris Therapeutics, Inc.
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jan 2012
Teva Announces Management Succession
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Dec 2011
Dr. Rob Koremans to succeed Dr. Gerard van Odijk as President and CEO of Teva Europe
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Dec 2011
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 16 Nov 2011
Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Oct 2011
Teva Completes Acquisition of Cephalon
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 31 Aug 2011
Dendreon Appoints John E. Osborn EVP & General Counsel
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Jul 2011
Yaupon Therapeutics, Inc. Appoints New Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2011
Teva to Acquire Taiyo
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 9 May 2011
Yaupon Therapeutics Names Steve Tullman Chairman and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2011
Watson Confirms District Court Ruling in Generic Fentora(R) Patent Suit
Biopharmaceuticals Generics
 HSMN NewsFeed - 24 Mar 2011
Cephalon Wins FENTORA Patent Suit Against Watson
Biopharmaceuticals Pain Management Generics Litigation
 HSMN NewsFeed - 21 Mar 2011
Cephalon Announces Definitive Agreement to Acquire Gemin X
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jan 2011
Labopharm Announces Executive Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jan 2011
Celator(R) Pharmaceuticals and Cephalon, Inc. Agree to Extend Research Agreement into Next Phase of Development
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Dec 2010
Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Dec 2010
Cephalon Appoints J. Kevin Buchi as Chief Executive Officer and Member of Cephalon Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Sep 2010
Celator(R) Pharmaceuticals Raises $20 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Jul 2010
TARIS Appoints Sarma Duddu as President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Apr 2010
Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 Apr 2010
Cephalon Completes Acquisition of Ception Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Feb 2010
Aton Pharma Announces Michael H. Richardson to Head Orphan Drug Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2010
Cephalon, Inc. Announces Agreement to Acquire Mepha AG
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Jan 2010
Ligand Completes Acquisition of Metabasis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Jan 2010
Cephalon Announces Executive Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Jan 2010
Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil(R)
Biopharmaceuticals Generics FDA Litigation
 HSMN NewsFeed - 8 Jan 2010
Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2010
Sopherion Therapeutics Receives FDA Fast Track Designation for Myocet in Metastatic Breast Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Dec 2009
Ligand Announces Positive Regulatory Opinion in Europe for Revolade for Chronic Immune Thrombocytopenic Purpura
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 17 Dec 2009
AMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2009
Dennis Winger Joins Nektar Therapeutics' Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Dec 2009
Cephalon Files Patent Infringement Lawsuit Against Teva Pharmaceuticals
Biopharmaceuticals Generics Litigation FDA
 HSMN NewsFeed - 5 Nov 2009
Pivotal Data Published in the Journal Cancer Demonstrate that TREANDA Induced Durable Responses in Relapsed Indolent Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Oct 2009
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Oct 2009
Ligand to Acquire Metabasis for Cash and Contingent Value Rights
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Oct 2009
Cephalon Signs Option Agreement to Acquire BioAssets Development Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2009
Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Sep 2009
Accuray Announces Additions to Board of Directors
Devices Oncology Personnel
 HSMN NewsFeed - 31 Jul 2009
Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Jun 2009
Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Jun 2009
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2009
Cephalon Announces the Availability of NUVIGIL for the Treatment of Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder and Narcolepsy
Biopharmaceuticals
 HSMN NewsFeed - 5 May 2009
Clarient Launches New Breast Cancer Test
Diagnostics Oncology
 HSMN NewsFeed - 27 Apr 2009
Ligand Announces Approval in Europe of CONBRIZA for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Mar 2009
FABLYN Approved in Europe for the Treatment of Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Mar 2009
Pfizer's Oncology Business Unit Appoints Senior Executive to Head U.S. Region
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Mar 2009
Sopherion Therapeutics Announces Completion of Enrollment in Phase III Study of Myocet in Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Mar 2009
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2009
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Feb 2009
Sopherion Therapeutics Announces Appointment of New Senior Executive Vice President for Clinical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2009
Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 13 Jan 2009
Cephalon Signs Option Agreement to Acquire Ception Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 9 Jan 2009
Azur Pharma Announces the Licensing of Niravam, Parcopa, Kemstro and Fluxid From UCB
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Jan 2009
Impax Confirms Patent Challenge Relating to Amrix (R) Extended-Release Capsules, 15mg and 30mg
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Jan 2009
Adolor Corporation Announces Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Nov 2008
Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Nov 2008
David R. King Joins Diasome Pharmaceuticals as Chairman of the Board
Biopharmaceuticals Endocrinology Drug Delivery Personnel
 HSMN NewsFeed - 3 Nov 2008
Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Oct 2008
Cephalon and Eurand Announce Notification of Generic Filing for Cyclobenzaprine Hydrochloride Extended-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Sep 2008
Adolor Appoints John M. Limongelli as Senior Vice President, General Counsel and Secretary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Aug 2008
Pharmacopeia Announces Further Reductions to Workforce
Biopharmaceuticals
 HSMN NewsFeed - 4 Aug 2008
Alkermes Announces Approval of VIVITROL(R) for the Treatment of Alcohol Dependence in Russia
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 8 Jul 2008
Longitude Capital Closes $325 Million Life Sciences Fund
Venture Capital
 HSMN NewsFeed - 12 Jun 2008
Industry Veteran David R. King Joins Quaker BioVentures
Venture Capital
 HSMN NewsFeed - 3 Jun 2008
Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
Biopharmaceuticals Litigation Generics
 HSMN NewsFeed - 29 May 2008
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2008
Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Apr 2008
Cephalon Notified of Generic Fentanyl Buccal Tablet Filing
Biopharmaceuticals Generics
 HSMN NewsFeed - 22 Apr 2008
NCCN Updates Non-Hodgkin's Lymphoma Guidelines
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Apr 2008
Cephalon Announces European Commission Approval of EFFENTORA for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 10 Apr 2008
Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2008
Alba Therapeutics Announces Appointment of Bruce A. Peacock as its Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2008
Acusphere Licenses Hydrophobic Drug Delivery System to Cephalon for $10 Million
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 20 Mar 2008
Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 19 Mar 2008
Alkermes Announces Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 7 Mar 2008
Alkermes Receives Notice from Eli Lilly Terminating Inhaled Insulin Program
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 7 Mar 2008
Alkermes Provides Update on Inhaled Insulin Program
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 6 Mar 2008
inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
Biopharmaceuticals
 HSMN NewsFeed - 28 Feb 2008
Pharmacopeia Announces Management Team Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2008
FDA Accepts TREANDA(R) New Drug Application for the Treatment of Relapsed Indolent Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jan 2008
Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Biopharmaceuticals
 HSMN NewsFeed - 24 Jan 2008
Cephalon's EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 7 Jan 2008
Alkermes Announces Agreement for the Commercialization of VIVITROL in Russia/CIS
Biopharmaceuticals
 HSMN NewsFeed - 31 Dec 2007
Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Nov 2007
Ambit Biosciences Raises Over $49 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Nov 2007
Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Oct 2007
Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Oct 2007
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
Biopharmaceuticals Licensing
 HSMN NewsFeed - 4 Oct 2007
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Oct 2007
Nitec Pharma Expands Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Oct 2007
Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2007
Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Sep 2007
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 11 Sep 2007
Pharmacopeia Announces Senior Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2007
NeurogesX Appoints New Director to the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Aug 2007
FDA Grants Orphan Drug Designation to TREANDA, an Investigational Treatment for Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Aug 2007
Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 16 Aug 2007
AEterna Zentaris completes management team with the appointment of Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2007
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Jul 2007
Jan H. Egberts, M.D. Resigns as President and CEO of NovaDel Pharma
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jul 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Provigil(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jun 2007
Cephalon Announces Plans for New NDA Filing for TREANDA(R)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Jun 2007
Cephalon Receives FDA Approval of NUVIGIL(TM) for the Treatment of Excessive Sleepiness Associated with Three Disorders
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 May 2007
Victory Pharma, Inc. Announces Dr. Shawn A. Scranton as Vice President of Scientific Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 May 2007
Tulip BioMed Appoints New President and Chief Operating Officer; Chief Financial Officer Adds Secretary and Treasurer Titles
Devices Personnel
 HSMN NewsFeed - 1 May 2007
Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Apr 2007
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 18 Apr 2007
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
Biopharmaceuticals Devices Cardiology
 HSMN NewsFeed - 13 Apr 2007
FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia Treatment
Biopharmaceuticals FDA
 HSMN NewsFeed - 30 Mar 2007
Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Mar 2007
Cephalon Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Mar 2007
Alkermes Announces Senior Management Succession Plan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Feb 2007
NovaDel Pharma Announces the Completion of Its Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2007
Lundbeck USA Signs Lease Agreement to Establish U.S. Headquarters in King of Prussia, Pennsylvania
Biopharmaceuticals
 HSMN NewsFeed - 24 Jan 2007
Cephalon Comments on Study of its Leukemia Treatment Led by National Cancer Institute Cooperative Group
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Jan 2007
Italian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)
Biopharmaceuticals Neurology Licensing Distribution
 HSMN NewsFeed - 9 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 Jan 2007
Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration
Biopharmaceuticals Endocrinology Drug Delivery Licensing
 HSMN NewsFeed - 8 Jan 2007
Ambit Biosciences Appoints Wendell Wierenga, Ph.D., as Executive Vice President of Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2007
Alkermes and Indevus Announce Joint Collaboration to Develop Inhaled Formulation of Trospium Chloride for the Treatment of COPD
Biopharmaceuticals
 HSMN NewsFeed - 20 Dec 2006
Alkermes Announces Submission of New Drug Application for RISPERDAL(R) CONSTA(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 13 Dec 2006
Ambit Biosciences Announces Establishment of Clinical Oncology Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Dec 2006
Beijing Med-Pharm Corporation Enters Into an Agreement to Develop and Register Products for Cephalon, Inc. in China
Biopharmaceuticals
 HSMN NewsFeed - 7 Dec 2006
Cephalon Provides Update Related to Final NUVIGIL(TM) Labeling
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Dec 2006
Ambit Biosciences Appoints Kerry Kelly, J.D., as Vice President and General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Dec 2006
Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of CIMA LABS
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Nov 2006
Pharmacopeia Announces the Appointment of Vice President, Clinical and Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2006
Cephalon Announces Positive Results for FENTORA(TM) (fentanyl buccal tablet) for Breakthrough Pain in Patients with Chronic Low Back Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Oct 2006
Diatos Strengthens Management Team with the Appointment of New Chief Medical Officer and New Chief Sales & Marketing Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2006
Barr Launches Generic ACTIQ(R) Cancer Pain Management Product
Biopharmaceuticals Generics Drug Delivery
 HSMN NewsFeed - 25 Sep 2006
Cephalon Receives FDA Approval of FENTORA(TM) (fentanyl buccal tablet) for the Management of Breakthrough Pain in Patients with Cancer
Biopharmaceuticals Oncology Drug Delivery FDA
 HSMN NewsFeed - 13 Sep 2006
NuPathe Closes $15 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 Sep 2006
Merge Healthcare Announces New President and CEO and Additional Members to Board of Directors
Devices Personnel
 HSMN NewsFeed - 29 Jun 2006
Cephalon Receives Approvable Letter for FENTORA(TM) (fentanyl buccal tablet) for Management of Breakthrough Pain in Patients with Cancer
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 26 Jun 2006
Cephalon Announces Results from GABITRIL(R) Clinical Program in Generalized Anxiety Disorder
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2006
Celator Pharmaceuticals Appoints Industry Veteran Felix Botelho as Head of Commercial Development
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 102

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 102 additional stories matching:
Cephalon
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.